Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study
Influence of Body Mass Index on Gingival Health, White Spot Lesions, Whole Salivary Proinflammatory Cytokine and Adipokine Profile and Candida and Streptococcus Mutans Carriage Among Adolescents Undergoing Fixed Orthodontic Therapy
1 other identifier
observational
52
1 country
1
Brief Summary
The goal of this prospective observational study is to assess the influence of increased body mass index (BMI) on various oral health and orthodontic-related parameters in adolescents undergoing orthodontic therapy (OT) with braces. These parameters include gum inflammation, tooth decalcifications/discolorations, tooth alignment of lower incisors, and various inflammatory and microbiological parameters in the collected saliva and gum fluid of the patients. The primary purpose is to assess if an increased BMI is a risk factor for oral inflammation in adolescents undergoing OT. The main questions it aims to answer are:
- 1.Do patients with an increased BMI undergoing OT demonstrate increased microbial counts in the saliva compared to patients with normal BMI?
- 2.Do patients with increased BMI undergoing OT demonstrate increased gum inflammation, tooth discolorations, and higher levels of inflammatory markers in the saliva and gum fluid samples compared to patients with normal BMI? This study will include 2 study groups (patients with increased BMI-test group, and normal weight patients-control group). The participants will be asked to complete a study questionnaire, which will collect information regarding their demographics, their family socioeconomic and educational status, dietary habits, and oral health-related quality of life. The participants will also receive an oral examination (evaluation of their gum health), and they will have their intraoral photos taken, as well as an impression of their lower teeth (to create dental models). A saliva sample will be obtained by asking patients to passively "drool" in a tube, and a gingival fluid sample will be collected from the gums of the lower anterior teeth using thin paper strips. All these study procedures will be conducted at baseline (T1: before bonding of braces), and at an approximately 6-month follow-up visit (T2). Comparisons of these outcomes will be conducted between the two groups and across timepoints.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 22, 2022
CompletedFirst Submitted
Initial submission to the registry
October 15, 2025
CompletedFirst Posted
Study publicly available on registry
October 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
October 20, 2025
October 1, 2025
4.5 years
October 15, 2025
October 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Mean Change in Full-Mouth Bleeding Score (FMBS)
Bleeding on probing (BOP) will be assessed dichotomously (yes/no) at six sites per tooth (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual/palatal, mid-lingual/palatal, and disto-lingual/palatal) using a standardized periodontal probe by trained examiners. The full-mouth bleeding score (FMBS) will be calculated as the percentage of sites that bleed out of the total number of sites examined. Higher percentages indicate greater gingival inflammation.
Baseline (T1: before bonding of braces) and approximately 6 months follow-up (T2)
Mean Change in White Spot Lesion (WSL) Score (International Caries Detection and Assessment System (ICDAS))
Standardized intraoral and facial photographs will be taken using calibrated camera settings and stored in Dolphin Imaging Software. Each visible tooth surface will be examined for color, texture, and cavitation changes and scored using the International Caries Detection and Assessment System (ICDAS). Code 0 = sound surface; code 2 = visible white spot lesion; codes 3-4 = localized enamel breakdown or dentin shadowing; codes 5-6 = cavitated lesions extending into dentin. Because photos are obtained without air drying, code 1 will be excluded. The average WSL score per participant will be calculated by dividing the total ICDAS score by the number of surfaces assessed. Mean change = score at T2 minus score at T1. Higher scores indicate greater enamel decalcification.
Baseline (T1: before bonding of braces) and approximately 6 months follow-up (T2)
Mean Change in Salivary Microbial Counts of Candida albicans and Streptococcus mutans
Unstimulated whole saliva will be collected at baseline and follow-up. C. albicans will be cultured on CHROMagar™ Candida and confirmed via germ tube test from three colonies per sample. S. mutans will be cultured on Mitis Salivarius Bacitracin medium and identified by colony morphology. DNA-based microbial identification and oral microbiome sequencing with bioinformatics analysis will also be performed. Microbial counts will be reported per participant as colony-forming units per milliliter (CFU/mL) or relative abundance. Higher values indicate greater microbial load.
Baseline (T1: before bonding of braces) and approximately 6 months follow-up (T2)
Secondary Outcomes (8)
Mean Change in Body Mass Index (BMI)
Baseline (T1) and approximately 6 months follow-up (T2)
Mean Change in Full-Mouth Plaque Score (FMPS)
Baseline (T1) and approximately 6 months follow-up (T2)
Mean Change in Percentage of Sites with Probing Depth >3 mm
Baseline (T1) and approximately 6 months follow-up (T2)
Mean Change in Oral Dryness Score (Challacombe Scale)
Baseline (T1) and approximately 6 months follow-up (T2)
Mean Change in Little's Irregularity Index (Tooth Alignment)
Baseline (T1) and approximately 6 months follow-up (T2)
- +3 more secondary outcomes
Study Arms (2)
Increased BMI group (test group)
The increased BMI group will include patients with a BMI\>25.0 Kg/m2.
Normal BMI group (control groups)
The normal-BMI group will include patients with a BMI between 18.5 and 24.99 (Kg/m2).
Eligibility Criteria
Adolescent patients undergoing fixed orthodontic therapy at the Eastman Institute for Oral Health, University of Rochester, NY.
You may qualify if:
- adolescents (12-17 years old);
- patients scheduled to undergo comprehensive fixed orthodontic therapy (OT) (for at least 6 months with metal braces/wires) on both dental arches;
- patients with increased BMI (≥25.0 Kg/m2) (test-Group);
- patients with normal BMI \[18.5-24.99 (Kg/m2)\] (control-Group);
- patients with all 6 mandibular anterior teeth present and mild-to-moderate mandibular crowding (\<7.5 mm);
- patients and parents/guardians willing to provide signed assent/permission.
You may not qualify if:
- self-reported habitual tobacco product users;
- patients with self-reported medical diseases such as hepatic diseases, blood disorders, cardiovascular diseases, HIV, diabetes mellitus, and viral infections;
- patients with craniofacial syndromes and/or cleft lip and palate;
- pregnant and/or lactating females (by self/parent report);
- edentulous individuals;
- patients with active or a history of periodontitis;
- patients having undergone surgical and/or non-surgical periodontal therapy within the past 6 months;
- patients with physical and/or mental/cognitive disabilities who are decisionally-impaired and not able to consent/assent for themselves;
- patients who reported use of medications such as antibiotics, steroids (inhalers and/or pills), non-steroidal anti-inflammatory drugs, and antimicrobial mouth-rinses within the past 3 months or those who require prophylactic antibiotics prior to dental procedures;
- patients undergoing cancer therapy;
- underweight patients (BMI less than 18.5 Kg/m2);
- patients with oral mucosal lesions such as median rhomboid glossitis and lichen planus;
- patients with clinically visible carious teeth.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eastman Institute for Oral Health, University of Rochester
Rochester, New York, 14620, United States
Biospecimen
The investigators will collect and retain unstimulated whole salivary samples from the study participants. The investigators will also collect and retain gingival crevicular fluid samples, which will be collected with periopaper strips from the distal side of the six mandibular anterior teeth.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dimitrios Michelogiannakis, DDS, MS
Eastman Institute for Oral Health, University of Rochester
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Program Director of the Orthodontics Department
Study Record Dates
First Submitted
October 15, 2025
First Posted
October 16, 2025
Study Start
April 22, 2022
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
October 20, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared due to privacy concerns and the risk of re-identification, even with de-identified datasets. Additionally, the scope of consent obtained from participants during the trial does not include provisions for public sharing of individual-level data.